• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • News
  • Lifestyle
  • Wellness
  • Cuisine
  • Product Reviews
  • Subscribe
Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Cannabis News and Culture Magazine

Emerald Media News Subscription
  • Print Magazines
  • 100+ Minority-Owned Companies to Support
  • No Pipe, No Problem
  • Blunt vs. Joint
  • The Cost of Cannabis in Each State
  • Calculating Your Edibles Dosage
  • Flintts Mouthwatering Mints

AgMedica Bioscience Inc. Announces Strategic Investment in, and Exclusive Canadian Licencing Agreement with, Extraction Technology Company, Herbolea S.r.l.

October 20, 2018 by Emerald Media Group Leave a Comment

This information was provided by prnewswire

Send your Press Release here.

AgMedica Bioscience Inc. Announces Strategic Investment in, and Exclusive Canadian Licencing Agreement with, Extraction Technology Company, Herbolea S.r.l.

CHATHAM, ON, Oct. 18, 2018 /CNW/ – AgMedica Bioscience Inc. (“AGMEDICA” or the “Company”), a licensed producer of medicinal cannabis, is pleased to announce a strategic investment in, and exclusive licencing agreement with, Herbolea S.r.l. (“HERBOLEA”) (the “Agreement”), a company focused on the development of Bio-Herbolysis™, a patent-pending, disruptive extraction technology.  The unique Bio-Herbolysis™ extraction process does not utilize organic solvents or supercritical CO2, resulting in significantly lower capital and input costs, while maintaining the presence of volatile terpenes which give cannabis its characteristic flavour and aroma.

AGMEDICA and HERBOLEA plan to leverage the licensing agreement to deliver distinct and true full-spectrum extracts derived from fresh cannabis and hemp as well as traditional extracts from dried cannabis and hemp, to service the Canadian and German markets.  The two companies will focus the expertise of their respective management and scientific teams, based in Canada and Italy, to accelerate the development of therapeutic products for human and veterinary use.  This Agreement represents a significant milestone for AGMEDICA as part of the Company’s strategy to develop differentiated products that contribute to the continued evolution of the cannabis sector.  It also significantly enhances HERBOLEA’s ongoing efforts to expand the global use of Bio-Herbolysis™. Not only does the Agreement afford the two companies an improved ability to develop unique products, it is also anticipated that utilizing the Bio-Herbolysis™ technology will enable AGMEDICA to capture significant savings in the extraction process and realize lower costs associated with capacity scaling and ongoing production flexibility.

Under the terms of the Agreement, AGMEDICA has agreed to purchase a 25% equity position in HERBOLEA.  In addition, the Agreement grants AGMEDICA exclusive rights to utilize Bio-Herbolysis™ in the Canadian market, and a licence for the use of Bio-Herbolysis™ in the German market.  AGMEDICA will implement the Bio-Herbolysis™ process in their Canadian operations for use in the extraction of cannabis and hemp, both for AGMEDICA’s own products, and to offer as a service to other licenced cannabis producers.  The Agreement is anticipated to close in early December, 2018.

“We are very pleased with our strategic investment and licencing agreement with HERBOLEA, which provides AGMEDICA the opportunity to be first to market with a patented, disruptive and lower-cost extraction technology that can be used to develop a line of differentiated cannabis and hemp derived products.” said Dr. Trevor Henry, CEO of AGMEDICA. “Investing directly in HERBOLEA creates clear alignment between our respective companies as we collaborate, while giving AGMEDICA direct exposure to their continued success and growth.”

“We are delighted to have AGMEDICA providing a strategic investment to further validate the disruptive potential of Bio-Herbolysis™ in the production of true, full-spectrum cannabis extracts,” said Igino Angelini, CEO of HERBOLEA. “HERBOLEA is focused on expanding global adoption of this ground-breaking proprietary extraction technology that will deliver differentiated cannabis extracts to a market that is forecast to experience rapid expansion.”

Filed Under: Press Release Tagged With: Press

Reader Interactions

Leave a Reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Subscribe to Emerald's Newsletter

loader

Advertise Here

Categories

Sustainability

seaweed naturals

SeaWeed Naturals Combines the Power of Seaweed with Cannabis to Further Ocean Restoration

April 3, 2022 By Maggie Horton

fungi climate change

Research Finds Fungi Help Ease Climate Change and Benefit the Environment

March 30, 2022 By Julia Meyer

climate crisis and the pandemic

“We Can Act:” What Bending the COVID-19 Curve Teaches Us About the Climate Crisis

April 21, 2020 By Melissa Hutsell

Footer

  • Subscribe
  • About
  • Contact
  • Privacy
  • Press

Recent

  • Are Pre-Rolls the Future of Cannabis Retail?
  • Oxalis Integrative Support Services
  • Unlocking the Future of Cannabis Consumption: Amedicanna’s Nano Emulsified Beverages
  • From Veterans to Entrepreneurs: How Emanuel Ledezma, Rudy Rendon, and Erwin Sibal Became Leaders in the Cannabis Industry 
  • Cannifest 2023

Search

Copyright © 2023 · The Emerald™ · News & Lifestyle Magazine

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Cannabis News and Culture Magazine
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.